The Korean company has seen all of its biosimilars approved under European review, and most of them have been launched, including the first Herceptin biosimilar in Europe.
Industry news
The Korean company has seen all of its biosimilars approved under European review, and most of them have been launched, including the first Herceptin biosimilar in Europe.
recently published
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.